DaVita HealthCare Partner (DVA)

Dialysis provider DaVita Inc. (NYSE:DVA) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 4.6% year on year to $3.58 billi...

IKC outperformance helped offset tech investment drag in Q3.

DaVita (NYSE:DVA) reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook. The kidney-care provider said its Integrated Kidney Care business outperformed expectations, though

Dialysis provider DaVita Inc. (NYSE:DVA) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 4.6% year on year to $3.58 bil...

Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting earnings this Thursday after the bell. Here’s what investors should know. DaVita beat analysts’ re...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at DaVita (NYSE:DVA) and its pee...

What Happened? Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 7.1% in the afternoon session after Axios reported that the Department of Health and H...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Berkshire is famous for buying stock when shares are notably undervalued.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...

DaVita has made Berkshire Hathaway a lot of money. Is Berkshire likely to hold onto the stock?

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

DaVita, Franklin Resources, and Archer Daniels Midland have each gained more than 30% year to date in 2026, offering investors diversification away from AI-driven stock market gains.

DaVita’s 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may hav...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...